Red blood cell and platelet transfusion support in the first 30 days after autologous stem cell transplantation: Real-world data
This cohort/real-world study was triaged for T1 - Hematologic Malignancies based on abstract review. It appears standard priority because it addresses a direct clinical or diagnostic question with moderate evidence maturity.
This cohort/real-world study was triaged for T1 - Hematologic Malignancies based on abstract review. It appears standard priority because it addresses a direct clinical or diagnostic question with moderate evidence maturity.
What the study was
- Study design
- Cohort/real-world study
- Sample size
- 331
- Maturity
- Validated
- Journal
- JPMA. The Journal of the Pakistan Medical Association
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.